| Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR | Eurosurveillance | 2020 | 4K |
| Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus | Journal of Virology | 2020 | 2.6K |
| Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan | Emerging Microbes and Infections | 2020 | 1.7K |
| Emerging coronaviruses: Genome structure, replication, and pathogenesis | Journal of Medical Virology | 2020 | 1.7K |
| Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle | Journal of Medical Virology | 2020 | 1.6K |
| Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 | Eurosurveillance | 2020 | 1.4K |
| Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China | Cell Host and Microbe | 2020 | 1.3K |
| The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients | Journal of Medical Virology | 2020 | 1.3K |
| Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure | Cell Host and Microbe | 2020 | 1.2K |
| Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes | Emerging Microbes and Infections | 2020 | 1.2K |
| The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro | Antiviral Research | 2020 | 1.1K |
| The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade | Antiviral Research | 2020 | 1K |
| Coronavirus infections and immune responses | Journal of Medical Virology | 2020 | 987 |
| Stability of SARS-CoV-2 in different environmental conditions | Lancet Microbe, The | 2020 | 967 |
| Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis | Journal of Medical Virology | 2020 | 961 |
| Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020 | Eurosurveillance | 2020 | 944 |
| Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody | Emerging Microbes and Infections | 2020 | 862 |
| Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020 | Eurosurveillance | 2020 | 842 |
| Tocilizumab treatment in COVID-19: A single center experience | Journal of Medical Virology | 2020 | 820 |
| Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures | Journal of Medical Virology | 2020 | 815 |
| Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China | Journal of Medical Virology | 2020 | 756 |
| COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis | Journal of Medical Virology | 2020 | 717 |
| Virology, Epidemiology, Pathogenesis, and Control of COVID-19 | Viruses | 2020 | 707 |
| Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies | Viruses | 2020 | 686 |
| Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients | Emerging Microbes and Infections | 2020 | 671 |
